Clinical Trials Browser

Phase 1/2 × Leukemia, Lymphoid × forodesine × Clear all

NCT00035022 2006-01-13

Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphoid, Lymphoma